Nivolumab drug can kill abestos cancer

Asbestos was once a popular building material, but it was discovered that exposure to it causes mesothelioma cancer.

Mesothelioma affects the lungs, and the lining surrounding the lower digestive tract. Symptoms are chest or lower back pain shortness of breath  and excessive sweating.

Nivolumab is effective for treating melanoma and kidney cancer it blocks PD-1 on the surface of T-cells, then activate immune system cells to hunt down and kill cancer cells.

It’s an example of immunotherapy, a type of cancer treatment which boosts the body’s natural defences in order to fight cancer.

haleplushearty.blogspot.com

Mesothelioma is getting better with immunotherapy drug

Mesothelioma is a type of cancer that develops in the lining of the lungs and chest wall, it is causes by inhalation of asbestos fibre.

It is difficult to detect the cancer at early stage because their is no symptoms until it reach an advanced stage.

An immunotherapy drug,
Pembrolizumab seems to be effective in the treatment of mesothelioma.

First-line therapy is the standard treatment for mesothelioma, according to Dr.Evan Alley, researchers have studied different drugs but have not seen positive results.

Pembrolizumab is a checkpoint inhibitor, it is designed to fight cancer by defeating process that cancer cells use to avoid being destroyed by the immune system.

Common adverse effect of the drug are: dry mouth, nausea, fatigue, and loss of appetite.